Dimensional Fund Advisors LP Cuts Position in National Research Co. (NASDAQ:NRC)

Dimensional Fund Advisors LP decreased its position in shares of National Research Co. (NASDAQ:NRC) by 3.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 614,495 shares of the company’s stock after selling 23,894 shares during the period. Dimensional Fund Advisors LP’s holdings in National Research were worth $14,103,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Norden Group LLC purchased a new position in National Research in the 1st quarter worth $5,170,000. US Bancorp DE grew its stake in shares of National Research by 85.3% during the first quarter. US Bancorp DE now owns 47,242 shares of the company’s stock valued at $1,871,000 after buying an additional 21,750 shares during the last quarter. Sei Investments Co. increased its holdings in shares of National Research by 45.2% in the first quarter. Sei Investments Co. now owns 61,770 shares of the company’s stock worth $2,447,000 after buying an additional 19,217 shares during the period. Cardinal Capital Management lifted its stake in shares of National Research by 63.3% in the 1st quarter. Cardinal Capital Management now owns 26,988 shares of the company’s stock valued at $1,072,000 after acquiring an additional 10,463 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in National Research by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 944,995 shares of the company’s stock valued at $37,431,000 after acquiring an additional 10,351 shares during the period. Institutional investors own 47.26% of the company’s stock.

National Research Price Performance

NRC opened at $19.97 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.37 and a quick ratio of 0.37. National Research Co. has a 1 year low of $19.92 and a 1 year high of $46.87. The stock’s 50 day simple moving average is $22.05 and its 200 day simple moving average is $27.30. The firm has a market cap of $476.82 million, a price-to-earnings ratio of 16.10 and a beta of 0.49.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. The company had revenue of $35.02 million for the quarter. National Research had a net margin of 20.01% and a return on equity of 63.64%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.40%. National Research’s dividend payout ratio is currently 38.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.